Form 4: Becton Dickinson Executive Sells Shares Under Pre-Arranged 10b5-1 Plan
SEC Form 4 Filing
Michael David Garrison, EVP & President of Medical at Becton Dickinson, sold 597 shares of common stock at $236.51 per share under a pre-arranged 10b5-1 trading plan.
Summary
- Michael David Garrison, an Executive Vice President and President of the Medical division at Becton Dickinson & Co, sold 597 shares of the company's common stock.
- The sale occurred on January 17, 2025, at a price of $236.51 per share.
- This transaction was executed under a pre-arranged trading plan, known as a Rule 10b5-1 plan, which was adopted on August 2, 2024.
- Following the transaction, Mr. Garrison directly owns 5,544 shares of Becton Dickinson common stock.
Sentiment
Score: 5
Explanation: The document reports a routine stock sale by an executive under a pre-arranged plan, which is neither positive nor negative for the company's outlook.
Industry Context
Executive stock sales are a common occurrence and are often part of pre-planned diversification strategies. The use of a 10b5-1 plan indicates that the sale was not based on any material non-public information.
Comparison to Industry Standards
- Executive stock sales are a common practice across publicly traded companies, including those in the medical device sector like Medtronic (MDT) and Abbott Laboratories (ABT).
- The use of a 10b5-1 plan is a standard method for executives to sell shares without raising concerns about insider trading, similar to practices at other large corporations.
- The volume of shares sold (597) is relatively small compared to the total outstanding shares of Becton Dickinson, and is not unusual for routine executive transactions.
Stakeholder Impact
- The impact on shareholders is likely to be minimal, as the transaction is a routine sale by an executive under a pre-arranged plan.
- There is no direct impact on employees, customers, suppliers, or creditors.
Key Dates
| Date | Description |
|---|---|
| 08/02/2024 | Date the Rule 10b5-1 trading plan was adopted by Michael David Garrison. |
| 01/17/2025 | Date of the stock sale transaction. |
| 01/21/2025 | Date the Form 4 was signed. |
Keywords
Becton Dickinson, BDX, insider trading, stock sale, Rule 10b5-1, executive, Michael David Garrison, share transaction
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.